Therapeutic efficiency of trimetazide MR in patients with type 2 diabetes mellitus after myocardial infarction
Aim. To evaluate efficiency of trimetazide MR combined with basic therapy of type 2 diabetes mellitus (DM2) in patients with myocardial infarction (MI). Materials and methods. The study included 106 patients with DM2 who underwent MI. Polycomponent basic therapy supplemented by trimetazideMR at a...
Guardado en:
Autores principales: | E E Novitskaya, G A Baryshnikova |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2d9d731b1a17475d8bd36d66acd209a2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diabetes mellitus type 2 and acute myocardial infarction: prognostic options for interaction in patients of different age groups
por: Alla A. Garganeeva, et al.
Publicado: (2018) -
Prognostic value of adipokines in patients with myocardial infarction and glucose metabolism disorders
por: Kamila Kahramonzhonovna Kholmatova, et al.
Publicado: (2014) -
The effect of empagliflozin on the development of chronic heart failure after myocardial infarction according to a 12-month prospective study
por: Alexey A. Nekrasov, et al.
Publicado: (2019) -
Myocardial revascularization in diabetic patients presenting with critical limbischemia
por: Ivan Ivanovich Dedov, et al.
Publicado: (2010) -
Antihyperglycemic therapy in patients with type 2 diabetes mellitus and ischaemic heart disease: management during acute period of myocardial infarction and interventional procedures
por: Olga Mikhailovna Smirnova, et al.
Publicado: (2012)